Figure 1From: Considerations for pre-clinical models and clinical trials of pluripotent stem cell-derived cardiomyocytes Overview of the key issues to be addressed before therapies based on pluripotent stem cell (PSC)-derived cardiomyocytes can be translated into clinical investigations. Back to article page